Janessa Laskin
Project LeaderWorking Group ChairMOHCCN Steering CommitteeResearcher
Projects
-
Canadian framework to improve predictive models for immunotherapy interventions (CAN-PREDICT-IT)
Developing multi-modal biomarkers to predict response to specific immunotherapies -
Orthogonal pangenome sequencing to unveil genetic cancer susceptibility diagnostic odysseys: a Return of Results Working Group new technology assessment study
Using long-read sequencing to reveal unknown hereditary links to cancer
Related News
-
Network Voices Conversation: Janessa Laskin, Personalized Onco-Genomics program co-lead
Natalie Kwadrans and Rosilene Kraft chat with Dr. Janessa Laskin, a BC-based oncologist and researcher, about precision medicine in Canada today and how the Network is supporting projects like the Per... -
New study highlights long-read sequencing applications in precision oncology
A team of researchers that includes Marathon of Hope Cancer Centres Network members demonstrate applications for long-read sequencing in precision oncology in a new study published in Cell Genomics. -
Marathon of Hope Cancer Centres Network and Canadian Cancer Trials Group partner on three pan-Canadian projects aimed at making immunotherapy more effective for cancer patients
A new partnership between the Marathon of Hope Cancer Centres Network (MOHCCN) and the Canadian Clinical Trials Group (CCTG) will support three pan-Canadian research teams aiming to better understand ...
Network Voices
-
Regional Consortia
BC Cancer Consortium
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more
-
